(Q35689787)

9 August 2017

1 reference

title

SARS: pharmacotherapy (English)

1 reference

9 August 2017

0 references

0 references

Kenneth Tsang

1

1 reference

9 August 2017

Nan Shan Zhong

series ordinal

2

1 reference

9 August 2017

publication date

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

8 Suppl

1 reference

9 August 2017

page(s)

S25-30

1 reference

Management of severe acute respiratory syndrome: the Hong Kong University experience.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Lung pathology of fatal severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Managing SARS amidst uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Aminopeptidase N inhibitors and SARS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Is traditional Chinese medicine useful in the treatment of SARS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Our strategies for fighting severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Severe acute respiratory syndrome (SARS) in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Development of a standard treatment protocol for severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

21 January 2018

Asia's nuclear family

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

Treatment of SARS with human interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2003.00525.X

10.1046/J.1440-1843.2003.00525.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference